生物电阻抗参数与透析中血压升高的关联
该研究为Frequent Hemodialysis Network Daily Trial的事后分析(n=234,800次访视),采用随机效应回归评估生物电阻抗向量长度与透析后收缩压及透析中血压升高的关联。结果显示,较短的向量长度(每50 Ω/m)与较高的透析后收缩压(2.9 mm Hg;95%CI 1.6-4.3)及透析中高血压风险升高(OR 1.66;95%CI 1.07-2.55)独立相关。
要点
- 向量长度每缩短50 Ω/m,透析后收缩压平均升高2.9 mm Hg。
- 向量长度每缩短50 Ω/m,透析中高血压风险OR为1.66。
- 更严格定义下OR为2.17,但95%CI 0.88-5.36。
核心结论
- 较短的向量长度(高血容量的生物电阻抗替代指标)与较高的透析后收缩压及透析中高血压风险独立相关。
研究设计与样本
- Frequent Hemodialysis Network Daily Trial的事后分析,纳入234例维持性血液透析患者,使用基线、1、4、12个月访视数据(n=800),采用随机效应回归模型。
主要发现
- 向量长度每缩短50 Ω/m,与透析后收缩压升高2.9 mm Hg(95%CI 1.6-4.3)相关。
- 向量长度每缩短50 Ω/m,与透析中高血压风险升高相关(OR 1.66;95%CI 1.07-2.55)。
- 采用更严格定义(透析前后收缩压升高>10 mm Hg)时,向量长度每缩短50 Ω/m与透析中高血压风险相关(OR 2.17;95%CI 0.88-5.36)。
关键数值与推荐
- 透析中高血压定义为透析前至透析后血压升高,影响5%-15%的维持性血液透析患者。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intradialytic hypertension, defined as an increase in BP from pre- to post-hemodialysis (HD), affects 5%-15% of patients receiving maintenance HD and is associated with cardiovascular and all-cause mortality. Hypervolemia is believed to be a major etiological factor, yet the association of more objective biomarkers of volume status with intradialytic hypertension is not well described. METHODS: In a post hoc analysis of the Frequent Hemodialysis Network Daily Trial ( n =234), using data from baseline, 1-, 4-, and 12-month visits ( n =800), we used random-effects regression to assess the association of bioimpedance estimates of volume (vector length) with post-HD systolic BP (continuous) and any increase in systolic BP (categorical) from pre- to post-HD. We adjusted models for randomized group; age; sex; self-reported race; Quételet (body mass) index; vascular access; HD vintage; hypertension; history of heart failure; diabetes; residual kidney function (urea clearance); pre-HD systolic BP; ultrafiltration rate; serum-dialysate sodium gradient; and baseline values of hemoglobin, phosphate, and equilibrated Kt/V urea. RESULTS: The mean age of participants was 50±14 years, 39% were female, and 43% were Black. In adjusted models, shorter vector length (per 50 Ω/m) was associated with higher post-HD systolic BP (2.9 mm Hg; 95% confidence interval [CI], 1.6 to 4.3) and higher odds of intradialytic hypertension (odds ratio 1.66; 95% CI, 1.07 to 2.55). Similar patterns of association were noted with a more stringent definition of intradialytic hypertension (>10 mm Hg increase from pre- to post-HD systolic BP), where shorter vector length (per 50 Ω/m) was associated with a higher odds of intradialytic hypertension (odds ratio 2.17; 95% CI, 0.88 to 5.36). CONCLUSIONS: Shorter vector length, a bioimpedance-derived proxy of hypervolemia, was independently associated with higher post-HD systolic BP and risk of intradialytic hypertension.
引用
- Elsayed E, Farag YMK, Ravi KS, et al. Association of Bioimpedance Parameters with Increases in Blood Pressure during Hemodialysis. Clin J Am Soc Nephrol. 2023. PMID: 37971865. doi:10.2215/CJN.0000000000000356
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。